This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
It can be very difficult to find companies that are both flying under the radar, and still might have potential for gains. Many times, stocks are off investors’ radar screens for a reason, though there are some hidden gems that could be worth uncovering by those with a high risk tolerance. One way to find these underappreciated stocks is by looking at companies that haven’t seen their share prices move higher lately, but have observed analysts raising earnings estimates for their stock.
PSB.PRV PSB.PRW PSB.PRX BCEI PSB.PRY SAM PSB PSB.PRS PSB.PRT PSB.PRU
Chicago, IL – July 13, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Bonanza Creek Energy, Inc. (BCEI - Free Report) , Cleveland-Cliffs Inc. (CLF - Free Report) , Foundation Building Materials, Inc. (FBM - Free Report) , The Manitowoc Company, Inc.
WFCNP WFC.PRL WCG WFC.PRJ SAM ACBI WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN DXC.WI WFC.PRY WFC.PRX DXC WFC.PRW WFC.PRV WFC WFC.WS ALGN FBM DECK CPST BCEI MLNX ADM MTW SAIC
Chicago, IL – July 12, 2018 – Zacks Equity Research highlights Bonanza Creek Energy, Inc. (BCEI - Free Report) as the Bull of the Day, Yum China Holdings, Inc. (YUMC - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Workday, Inc. (WDAY - Free Report) , Adobe Systems Inc. (ADBE - Free Report) and Progress Software Corp. (PRGS - Free Report) .
ROP YUMC WDAY EVRI ADP BCEI TRTN ADBE DK ADPVV PRAH LULU WNC HEAR PRGS
Second-quarter earnings season has commenced, which means investors are closely watching how corporate America performed in the three months ended June. The outcome seems to be quite encouraging, as U.S. companies are expected to see one of the strongest quarterly earnings season in almost a decade.
FBM MLNX BCEI MTW ACBI
Bonanza Creek Energy, Inc. (BCEI - Free Report) is cashing in on higher crude prices and strong demand. This Zacks Rank #1 (Strong Buy) is expected to see earnings jump nearly 300% in 2018. Bonanza Creek is a small cap exploration and production company headquartered in Denver, Colorado. With a market cap of $720 million, it has operations in the Wattenberg Field in Colorado and the Cotton Valley sands of Southern Arkansas in the Mid-Continent.
LMT CVRR BCEI
Earnings estimates for Bonanza Creek Energy, Inc. (BCEI - Free Report) have been revised upward over the past 30 days, reflecting analysts’ confidence in the stock. The Zacks Consensus Estimate for 2018 earnings has moved 11.7% north to $5.32 per share in last 30 days. Bonanza Creek Energy is an independent energy exploration and production company that the extraction of oil and associated liquids-rich natural gas in the United States.
COP BCEI OXY
Suncor Energy Inc. (SU - Free Report) recently announced that its Syncrude oil sands project in Alberta is likely to resume full production in September. Following a power outage in Jun 20, the Syncrude project went offline. The disruption resulted from a transformer trip that caused power loss and steam generation. While no casualty was recorded from the outage, all the process units of the facility have been shut down since then.
IMO BCEI IMO SU SU
Cheniere Energy, Inc. (LNG - Free Report) recently received approval from Federal Energy Regulatory Commission (FERC) to introduce fuel gas for testing Train 1 of its Corpus Christi liquefaction (CCL) project. While the fuel gas will help make the train operational, the company will seek another approval from FERC to introduce feed gas to start the process of gas liquefaction. Cheniere Energy is likely to commence gas liquefaction at Train 1 in early September and start exporting its first test cargo in December/January.
ECR CQP LNG CVRR BCEI GPRK
Chicago, IL –July 5, 2018 – Zacks Value Trader is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:
CRR 6755 HP CVX FGELF STX BCEI SMCI FANG
Cheniere Energy, Inc. (LNG - Free Report) , riding high on its first-mover advantage in exporting liquified natural gas from the United States, recently inked a major deal with Taiwan’s CPC Corporation. Per the deal, Cheniere Energy will supply two million tons of liquified natural gas (LNG - Free Report) annually to CPC for 25 years. Cheniere Cashing in on Shifting Trends Considering the secular shift to cleaner burning fuel for power generation worldwide and in the Asia-Pacific region in particular, Cheniere Energy is likely to cash in on the development.
ECR CQP BLT BHP LNG BHPBF BBL BHP BCEI GPRK BHPLF
Oasis Petroleum, Inc. (OAS - Free Report) recently inked two separate deals to offload some of its non-operating assets in the Williston Basin, in a bid to upgrade its portfolio. The transaction is valued at $283 million. However, details of the buyers have been kept under wraps. The divested non-core assets comprise 65,000 acres in North Dakota and Montana, having an estimated production capacity of 4,400 barrels of oil equivalent per day (Boe/d).
OAS DVN CXO BCEI ICHR
Parsley Energy, Inc. (PE - Free Report) appears to be a solid bet based on strong fundamentals, robust financials along with healthy share price performance. Shares of Parsley have gained 15.8% in the past two years, vis-à-vis the stocks in this industry that have collectively lost 5%.
DVN PE CXO BCEI ICHR
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
as of ET